Key Financial’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLRB
Key Financial's CLRB Position: Q3 2026 in Review
Key Financial opened a new position in Cellectar Biosciences (CLRB) in Q3 2026: 3 shares worth $6. The stake represents ﹤0.01% of the portfolio and ranks #1309 among its holdings.
20 funds tracked by Wall St. Rank hold CLRB as of Q3 2026.
- Key Financial held 3 shares of Cellectar Biosciences worth $6 as of Q3 2026.
- Cellectar Biosciences was a new Key Financial position in Q3 2026.
- Cellectar Biosciences made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1309 holding.
- 20 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.